WO1994006800A1 - Procede pour l'obtention de lactone sesquiterpenique et notamment de parthenolide - Google Patents
Procede pour l'obtention de lactone sesquiterpenique et notamment de parthenolide Download PDFInfo
- Publication number
- WO1994006800A1 WO1994006800A1 PCT/FR1993/000938 FR9300938W WO9406800A1 WO 1994006800 A1 WO1994006800 A1 WO 1994006800A1 FR 9300938 W FR9300938 W FR 9300938W WO 9406800 A1 WO9406800 A1 WO 9406800A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- extraction
- pressure
- temperature
- fluid
- extraction fluid
- Prior art date
Links
- BUQLXKSONWUQAC-UHFFFAOYSA-N Parthenolide Natural products CC1C2OC(=O)C(=C)C2CCC(=C/CCC1(C)O)C BUQLXKSONWUQAC-UHFFFAOYSA-N 0.000 title claims abstract description 28
- KTEXNACQROZXEV-PVLRGYAZSA-N parthenolide Chemical compound C1CC(/C)=C/CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)C(=C)[C@@H]21 KTEXNACQROZXEV-PVLRGYAZSA-N 0.000 title claims abstract description 28
- 229940069510 parthenolide Drugs 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 27
- 229930009674 sesquiterpene lactone Natural products 0.000 title claims abstract description 9
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 title claims abstract description 9
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 title claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 54
- 239000012530 fluid Substances 0.000 claims abstract description 50
- 150000001875 compounds Chemical class 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 5
- 230000008569 process Effects 0.000 claims description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 12
- 230000004048 modification Effects 0.000 claims description 11
- 238000012986 modification Methods 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 6
- 239000001569 carbon dioxide Substances 0.000 claims description 6
- 230000015556 catabolic process Effects 0.000 claims description 5
- 239000006184 cosolvent Substances 0.000 claims description 5
- 238000006731 degradation reaction Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 4
- 230000000144 pharmacologic effect Effects 0.000 claims description 4
- 238000011084 recovery Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000009467 reduction Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 240000003538 Chamaemelum nobile Species 0.000 claims 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 4
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 4
- 235000008384 feverfew Nutrition 0.000 description 4
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 3
- 244000042664 Matricaria chamomilla Species 0.000 description 3
- AVFIYMSJDDGDBQ-UHFFFAOYSA-N Parthenium Chemical compound C1C=C(CCC(C)=O)C(C)CC2OC(=O)C(=C)C21 AVFIYMSJDDGDBQ-UHFFFAOYSA-N 0.000 description 3
- 241001495454 Parthenium Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- -1 parthenolide Chemical class 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Definitions
- the present invention relates to a process for obtaining sesquiterpene lactone and in particular parthenolide.
- the invention relates to the extraction of a fraction rich in parthenolide from the aerial part of plants naturally containing this compound and more especially from the chamomile.
- Parthenolide corresponds to the formula developed below
- Parthenolide is a sesquiterpene lactone with pharmacological properties and known to reduce in particular the frequency and intensity of headaches and migraines.
- REPLACEMENT SHEET in a part of the American continent. It has been used for a long time in the United Kingdom in folk medicine to treat fever (hence its name Fever few), arthritis and all headaches.
- Fever few fever
- the invention aims to implement a process for obtaining sesquiterpene lactones and in particular parthenolide from an extraction medium consisting of supercritical fluids or liquids under pressure.
- the invention relates to a process for obtaining sesquiterpene lactone and in particular parthenolide, a process avoiding the degradation of the compound during extraction, and the process is characterized by the selection of plants containing the desired compound and used contact with an extraction fluid by dissolving the desired compound and said extraction fluid consists of a supercritical fluid or a liquid under pressure, the extraction fluid is removed after a time
- SHEET OF R ⁇ MFLA ⁇ ⁇ IENT of appropriate contact and the temperature and / or pressure conditions are modified so as to lower the solvent power of the extraction fluid then brought to the gaseous state and discharged, the desired compound being collected in the form of a solid, pasty extract or liquid.
- the vegetable products from which operates the extrac ⁇ consist of the aerial part of the plant referred to as Feverfew.
- the pressure and temperature conditions are such that the pressure is greater than the critical pressure and the temperature is greater at the critical temperature.
- the pressure and temperature conditions are such that the pressure is lower or higher than the critical pressure and the temperature is lower than the critical temperature.
- the invention uses the properties of supercritic fluids or pressurized liquids having, under appropriate and sufficient temperature and pressure conditions, an increased dissolving power with respect to constituents while limiting the risks of degradation of compounds sensitive to the action of organic or thermosensitive solvents or also sensitive to oxidation.
- the extraction fluid comprises a percentage of between 0 and 20% of co-solvent.
- the co-solvent consists of water or an organic solvent, in particular ethanol.
- P ACEMENT An advantageous embodiment of the invention uses carbon dioxide in the state of supercritical fluid or liquid under pressure.
- this product has the particularities of being inexpensive and abundant while being free of toxic effects; furthermore, its critical pressure and temperature are low and correspond respectively to 73 bar and 31.3 ° C.
- the substance containing the desired constituents is introduced into an extractor and the starting substance is brought into contact with the extraction fluid brought to the desired temperature and pressure conditions, after a contact time.
- the extraction fluid loaded with the desired compounds is recovered and subjected to a modification of the physical conditions of pressure and / or temperature which lead to lowering its solvent power thereby allowing the extraction of the extracted compound, the extraction fluid in the form gas being evacuated.
- the extraction fluid after modification of the thermal and / or pressure conditions aimed at ensuring the separation of the extracted compound is recycled after having undergone a modification of the temperature and / or pressure conditions so as to bring it back to the state of supercritical fluid or fluid under pressure suitable for ensuring a new phase of extraction.
- the gas phase extraction fluid is compressed to be brought to the desired pressure and then cooled to the desired temperature for recycling.
- the gas phase extraction fluid is cooled to be condensed, then pumped and heated to bring it to the pressure and temperature conditions for recycling in the extractor.
- the plant containing parthenolide in particular the chamomile, is introduced into at least one extractor within which the plant charge is brought into contact with the extraction fluid consisting of carbon dioxide and the temperature of which is brought to a level between 10 and 60 ° C and the pressure between 60 and 500 bar.
- the phase of separation of the extract from the extraction fluid is carried out in one or more separators arranged in series, in particular of the cyclone type.
- the separation between the extraction fluid and the extracted compound is obtained by simple reduction of pressure without modification of temperature, the pressure being lowered to a level between 0 and 100 bar.
- the recovery of the extracts consisting of the desired compound is carried out by simple collection of the separate extracts.
- this recovery can be carried out by trapping the extract in the separators on a liquid or solid support, this during the extraction phase and during the modification or modifications of the physical conditions of the extraction fluid aimed at reducing its solvent power to allow separation in the form of a dry extract of the desired compound.
- the extraction fluid consists of carbon dioxide comprising between 0 and 20% of a co-solvent consisting of alcohol or water.
- the extraction is carried out at a temperature between 30 and 60 ° and at a pressure between 150 and 300 bar.
- the invention also relates to the compounds, in particular the parthenolide extracted according to the above operating phases and having improved pharmacological properties thanks to the purity of the product and to the absence of degradation linked to non-aggressive extraction methods.
- the invention also relates to the therapeutic preparations comprising as active ingredient at least the parthenolide extracted in accordance with the above process.
- the invention uses the properties of supercritical fluids or liquids under pressure under temperature and pressure conditions giving this extraction fluid an increased dissolving power vis-à-vis the desired compounds and to be extracted at within the raw material made up here of a load of chamomile (flowers, leaves, stems).
- Parthenolide is assayed by HPLC.
- the load is extracted at 280 bar and 60 ° C with the addition of 25ml of water every 60 minutes; for a total solvent level of 130 kg of CO 2 per kg of feed, an extract yield of 1.78% is obtained relative to the dry matter, the extract containing 28% of parthenolide.
- the parthenolide concentration in the final residue is ⁇ 10 "4 %
- the same charge treated at 280 bar and 35 ° C. has an extract yield of 2.22% relative to the dry matter, for a solvent content of 220 kg of CO 2 per kg of charge; the richness of the parthenolide extract is then 24.9%.
- the parthenolide concentration in the final residue is 0.04%
- the same charge treated at 180 bar and 35 ° C has an extract yield of 2.49% relative to the dry matter, for a solvent content of 220 kg of CO 2 per kg of charge; the richness of the parthenolide extract is then 32.5%.
- the parthenolide concentration in the final residue is 0.08%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Extraction Or Liquid Replacement (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93920933A EP0614459A1 (fr) | 1992-09-24 | 1993-09-24 | Procede pour l'obtention de lactone sesquiterpenique et notamment de parthenolide |
AU48241/93A AU4824193A (en) | 1992-09-24 | 1993-09-24 | Method for obtaining sesquiterpene lactone, in particular parthenolide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR92/11399 | 1992-09-24 | ||
FR9211399A FR2695931B1 (fr) | 1992-09-24 | 1992-09-24 | Procédé pour l'obtention de lactone sesquiterpénique de parthénolide, et préparation thérapeutique contenant un tel produit pour le traitement de la migraine. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994006800A1 true WO1994006800A1 (fr) | 1994-03-31 |
Family
ID=9433850
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1993/000938 WO1994006800A1 (fr) | 1992-09-24 | 1993-09-24 | Procede pour l'obtention de lactone sesquiterpenique et notamment de parthenolide |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0614459A1 (fr) |
AU (1) | AU4824193A (fr) |
FR (1) | FR2695931B1 (fr) |
WO (1) | WO1994006800A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19800330A1 (de) * | 1998-01-07 | 1999-07-08 | Mueller Extract Company Gmbh & | Verfahren zur Herstellung eines pharmazeutisch wirksamen CO¶2¶-Extraktes aus Tanacetum parthenium sowie pharmazeutisch wirksamer Extrakt |
WO1999033463A1 (fr) * | 1997-12-23 | 1999-07-08 | Moser, René | LACTONES SESQUITERPENE INHIBANT SPECIFIQUEMENT L'ACTIVATION DU NF-λB EN EMPECHANT LA DEGRADATION DES PROTEINES IλB-α et IλB-$g(b) |
US6410062B1 (en) | 1999-06-03 | 2002-06-25 | Johnson & Johnson Consumer France Sas I3540 | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US7192614B2 (en) | 2002-11-05 | 2007-03-20 | Gelstat Corporation | Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
US7229650B2 (en) | 1999-06-03 | 2007-06-12 | Johnson & Johnson Consumer France Sas | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US7547456B2 (en) | 2001-03-16 | 2009-06-16 | Johnson & Johnson Consumer Companies, Inc. | Composition containing feverfew extract and use thereof |
CZ301703B6 (cs) * | 1999-06-03 | 2010-06-02 | Indena S. P. A. | Extrakty Tanacetum parthenium |
US8409637B2 (en) | 2007-06-21 | 2013-04-02 | Puramed Bioscience Inc. | Compositions and methods for treating and preventing migrainous headaches and associated symptoms |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200301763A (en) * | 2002-01-07 | 2003-07-16 | Du Pont | Methylenelactones synthesis in supercritical fluids |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992011857A1 (fr) * | 1991-01-11 | 1992-07-23 | Rhodes Technology Ltd. | Procede d'extraction d'olides sesquiterpeniques |
EP0553658A2 (fr) * | 1992-01-31 | 1993-08-04 | Schaper & Brümmer Gmbh & Co. Kg | Compositions pharmaceutiquement actives à de Tanacetum parthenium, procédé d'extraction et médicament |
-
1992
- 1992-09-24 FR FR9211399A patent/FR2695931B1/fr not_active Expired - Fee Related
-
1993
- 1993-09-24 WO PCT/FR1993/000938 patent/WO1994006800A1/fr not_active Application Discontinuation
- 1993-09-24 AU AU48241/93A patent/AU4824193A/en not_active Abandoned
- 1993-09-24 EP EP93920933A patent/EP0614459A1/fr not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992011857A1 (fr) * | 1991-01-11 | 1992-07-23 | Rhodes Technology Ltd. | Procede d'extraction d'olides sesquiterpeniques |
EP0553658A2 (fr) * | 1992-01-31 | 1993-08-04 | Schaper & Brümmer Gmbh & Co. Kg | Compositions pharmaceutiquement actives à de Tanacetum parthenium, procédé d'extraction et médicament |
Non-Patent Citations (4)
Title |
---|
CHEMICAL ABSTRACTS, vol. 99, no. 8, 22 April 1983, Columbus, Ohio, US; abstract no. 58719b, E. STAHL ET AL.: "High-pressure extraction of natural substances with supercritical and liquefied gases. 13.Composition of carbon dioxide extracts of wormwood, obtained by fractionation" page 298; * |
PARFUEM. KOSMET., vol. 64, no. 5, 1983, pages 237 - 240 * |
R. M. SMITH ET AL: "Optimization of supercritical fluid extraction of volatile constituents from a model plant matrix", JOURNAL OF CHROMATOGRAPHY, vol. 600, no. 2, 29 May 1992 (1992-05-29), AMSTERDAM NL, pages 175 - 181 * |
R. M. SMITH ET AL: "Supercritical fluid extraction and gas chromatographic determination of the sesquiterpene lactone parthenolide in the medicinal herb feverfew (Tanacetum parthenium)", JOURNAL OF CHROMATOGRAPHY, vol. 627, no. 1-2, 25 December 1992 (1992-12-25), AMSTERDAM NL, pages 255 - 261, XP026514412, DOI: doi:10.1016/0021-9673(92)87205-M * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033463A1 (fr) * | 1997-12-23 | 1999-07-08 | Moser, René | LACTONES SESQUITERPENE INHIBANT SPECIFIQUEMENT L'ACTIVATION DU NF-λB EN EMPECHANT LA DEGRADATION DES PROTEINES IλB-α et IλB-$g(b) |
DE19800330A1 (de) * | 1998-01-07 | 1999-07-08 | Mueller Extract Company Gmbh & | Verfahren zur Herstellung eines pharmazeutisch wirksamen CO¶2¶-Extraktes aus Tanacetum parthenium sowie pharmazeutisch wirksamer Extrakt |
DE19800330C2 (de) * | 1998-01-07 | 2002-09-26 | Delta 9 Pharma Gmbh | Pharmazeutisch wirksamer CO¶2¶-Extrakt aus Tanacetum parthenium |
US6410062B1 (en) | 1999-06-03 | 2002-06-25 | Johnson & Johnson Consumer France Sas I3540 | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US7229650B2 (en) | 1999-06-03 | 2007-06-12 | Johnson & Johnson Consumer France Sas | Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium) |
US7387807B2 (en) | 1999-06-03 | 2008-06-17 | Johnson & Johnson Consumer France, Sas, Roc Division | Topical composition comprising feverfew |
CZ301703B6 (cs) * | 1999-06-03 | 2010-06-02 | Indena S. P. A. | Extrakty Tanacetum parthenium |
US7547456B2 (en) | 2001-03-16 | 2009-06-16 | Johnson & Johnson Consumer Companies, Inc. | Composition containing feverfew extract and use thereof |
US7192614B2 (en) | 2002-11-05 | 2007-03-20 | Gelstat Corporation | Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
US8409637B2 (en) | 2007-06-21 | 2013-04-02 | Puramed Bioscience Inc. | Compositions and methods for treating and preventing migrainous headaches and associated symptoms |
Also Published As
Publication number | Publication date |
---|---|
FR2695931B1 (fr) | 1994-10-28 |
EP0614459A1 (fr) | 1994-09-14 |
FR2695931A1 (fr) | 1994-03-25 |
AU4824193A (en) | 1994-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9994794B2 (en) | Method for extracting cinnamon oil | |
EP1055439A2 (fr) | Extraction de parfums | |
WO1994006800A1 (fr) | Procede pour l'obtention de lactone sesquiterpenique et notamment de parthenolide | |
CN1146303A (zh) | 香辛料油树脂微胶囊的生产工艺 | |
CN105018235A (zh) | 一种从玫瑰鲜花中快速提取玫瑰精油的方法 | |
EP0077745B1 (fr) | Modification de la composition de boissons alcoolisées obtenus par fermentation de fruits par utilisation de CO2 liquide | |
WO2000064555A3 (fr) | Procede d'extraction par solvants | |
WO2007029264A2 (fr) | Procede d'isolement d'un extrait de solanesol a partir du tabac au moyen d'un traitement d'extraction de fluide co2 supercritique | |
Maness et al. | Quantitative extraction of pecan oil from small samples with supercritical carbon dioxide | |
CN101407744B (zh) | 用亚临界压力脉动法从甘蔗制糖滤泥中提取蔗蜡的工艺 | |
CN1073562C (zh) | 超临界二氧化碳从银杏叶中萃取含有原花青素提取物的方法 | |
CN104083556B (zh) | 一种从魔芋中提取魔芋神经酰胺的方法 | |
WO2021050000A1 (fr) | Procédé de préparation d'un extrait de patchouli | |
CN106398867A (zh) | 一种马里兰烟提取物的制备方法及其在卷烟中的应用 | |
CN105112163A (zh) | 一种从荆芥叶中提取烟用挥发油的方法 | |
CN1966499B (zh) | 超临界流体萃取橄榄黄酮方法 | |
EP1122259A2 (fr) | Extraction de la fraction céroide du résidu résireux de fabrication de l'aggloméré noir de liège avec un fluide supercritique | |
FR2706166A1 (fr) | Procédé d'extraction d'artémisinine. | |
WO2004026430A3 (fr) | Extraction | |
CN1927875A (zh) | 一种以乙醇为夹带剂的红景天苷co2超临界萃取方法 | |
US20220265745A1 (en) | Methods of Extraction of Plant Materials and Extracts Obtained Using Supercritical Glycerin | |
KR20060093145A (ko) | 초임계유체 추출공정을 이용한 포도씨기름의 제조 방법 | |
CN104738251A (zh) | 一种亚临界流体萃取茶叶提取物的方法 | |
BRPI0903275A2 (pt) | processo de extração e purificação de artemisinina a partir de massa sólida de artemisia annua utilizando dióxido de carbono | |
JPS59141528A (ja) | エタノ−ル水溶液の濃縮法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993920933 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1993920933 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993920933 Country of ref document: EP |